Diabetes Education for Patients With Type 2 Diabetes in Turkmenistan

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06728501

Enrollment

114

Registered

2024-12-11

Start date

2022-02-01

Completion date

2022-07-31

Last updated

2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The aim of the study is to investigate whether structured diabetes mellitus education leads to improved blood glucose control in Turkmenistan.

Detailed description

Diabetes education is not routinely carried out in Turkmenistan. The aim of the study is to investigate whether patients with type 2 diabetes benefit from an International Diabetes Federation (IDF) based education program. Patients will be randomized into a education group and a control group. The education group will receive 4 - 5 hours of education and the control group will only receive general information about diabetes mellitus. After 6 months, it is checked whether the change in the HbA1c value differs between the two groups. Additinal paremeters such as blood pressure, diabetes knowledge and lipids will also be evaluated (secondary parameters).

Interventions

BEHAVIORALDiabetes education

Patients receive 5 hours of diabetes education

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* type 2 diabetes

Exclusion criteria

* type 1 diabetes * diabetes duration \< 1 year * severe comorbidities * abuse of alcohol or drugs * pregnancy

Design outcomes

Primary

Measure	Time frame
Change in HbA1c	6 months

Countries

Turkmenistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026